Effect of H. pylori Infection on L-DOPA Pharmacokinetics in Patients with Parkinson's disease

被引：0
|
作者：
Oda, S.
Saitoh, Y.
Takei, J.
Watanabe, S.
Mukai, Y.
Takahashi, Y.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
519
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [21] Unpredictable Rotational Responses to L-dopa in the Rat Model of Parkinson's Disease: the Role of L-dopa Pharmacokinetics and Striatal Dopamine Depletion
    Kaariainen, Tiina M.
    Kaenmaki, Mikko
    Forsberg, Markus M.
    Oinas, Niko
    Tammimaki, Anne
    Mannisto, Pekka T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 110 (02) : 162 - 170
  • [22] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    Amino Acids, 2005, 28 : 157 - 164
  • [23] Monitoring of L-dopa concentrations in Parkinson's disease
    Furlanut, M
    Furlanut, M
    Benetello, P
    PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 423 - 427
  • [24] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212
  • [25] Focusing Effects of L-Dopa in Parkinson's Disease
    Ng, Bernard
    Palmer, Samantha
    Abugharbieh, Rafeef
    McKeown, Martin J.
    HUMAN BRAIN MAPPING, 2010, 31 (01) : 88 - 97
  • [26] Conversion of L-dopa to Extended Release L-dopa (Rytary®) in Patients with Fluctuating Parkinson's Disease: Predictors of Dose
    Ondo, William
    Coss, Pablo
    Christie, Melissa
    Pascual, Belen
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (01) : 153 - 156
  • [27] Peculiarities of L-DOPA treatment of Parkinson's disease
    Kostrzewa, RM
    Nowak, P
    Kostrzewa, JP
    Kostrzewa, RA
    Brus, R
    AMINO ACIDS, 2005, 28 (02) : 157 - 164
  • [28] Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration
    Lamberti, P
    Zoccolella, S
    Armenise, E
    Lamberti, SV
    Fraddosio, A
    de Mari, M
    IIiceto, G
    Livrea, P
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (05) : 365 - 368
  • [29] Effectiveness of Continuous Dopaminergic Therapies in Parkinson's Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics
    Demailly, Alexandre
    Moreau, Caroline
    Devos, David
    JOURNAL OF PARKINSONS DISEASE, 2024, 14 (05) : 925 - 939
  • [30] In idiopathic Parkinson's disease: The effect of using L-dopa on peripheral nerves
    Temir, M. E.
    Genc, F.
    Gomceli, Y. Bicer
    Yaman, A.
    Aybar, A.
    Karacay, E.
    MOVEMENT DISORDERS, 2016, 31 : S284 - S284
12345